Trial Profile
Pharmacokinetic comparison between branded versus generic rifaximin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Crohn's disease; Intestinal infections; Irritable bowel syndrome
- Focus Pharmacokinetics
- 06 Nov 2015 New trial record